Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon

NCT02202291 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT02202291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02202291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 13, 2014
Completion date
June 10, 2020
Enrollment
258 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

genetic mutations causing pr, primary raynaud's phenomenon (pr), study of patients and their relatives (with or without primary pr)